Riboflavin sodium phosphate

核黄素磷酸钠

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameRiboflavin sodium phosphate
Drug Alias Name核黄素磷酸钠盐Riboflavinum sodium phosphateRiboflavin 5'-phosphate sodiumRiboHyryl +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsRiboflavin DeficiencyKeratoconusCorneal Neovascularization +[4] 
Global Approved IndicationsRiboflavin DeficiencyKeratoconus
Approved Indications in ChinaRiboflavin Deficiency
Original Approved Country/TerritoryJapan
Original Approved Date1961/11/02
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesCornea And Laser Eye InstituteGlaukos CorpPrice Vision Group +[5] 
Inactive CompaniesN/A
Active IndicationsRiboflavin DeficiencyKeratoconusCorneal Neovascularization +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeS01XA26
Related LinksWikipediaDrugBankKEGG